Revenue
2022
2023
2024
2025
HeartSciences Inc. (HSCS)
Price—Loading quote
Net income
2022
2023
2024
2025
Free cash flow
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2021
2022
2023
2024
2025
2026
Financial statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $4,350 | $18,600 | $5,150 | $14,373 |
| Gross profit | $2,470 | $12,519 | $2,354 | $6,483 |
| Research & development | $4.4M | $2.9M | $2.5M | $3.0M |
| Operating expenses | $8.4M | $6.3M | $6.1M | $4.7M |
| Operating income | −$8.4M | −$6.3M | −$6.1M | −$4.7M |
| Net income | −$8.8M | −$6.6M | −$6.4M | −$4.8M |
| Basic EPSper diluted share | -$9.34 | -$18.74 | -$80.00 | -$1.45 |
| Diluted EPSper diluted share | -$9.34 | -$18.74 | -$80.00 | -$1.45 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 29, 2025Form 4 | HILZ MARK TCOO, Secretary and Director | SellCommon Stock, $0.001 par value | 4.4K | $3.54 | $15.6K | 4.8K |